Denmark medical cannabis sales post a positive quarter thanks to Epidiolex
Sales of medical marijuana in Denmark posted healthy gains in the third quarter of 2020, coinciding with the launch of GW Pharmaceuticals’ cannabis drug Epidiolex.
Survey: Majority in Germany still opposes adult-use cannabis legalization
A slim majority of eligible voters in Germany opposes legalizing recreational marijuana, according to a new poll.
Cannabis firm Canopy Growth sues GW Pharma, claiming patent infringement
Canadian cannabis producer Canopy Growth Corp. is suing Britain’s GW Pharmaceuticals in U.S. federal court, alleging that GW is knowingly infringing upon Canopy’s intellectual property.